GWS
EGRX

Glassman Wealth Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Glassman Wealth Services’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-59
Closed -$930 – 2096
2023
Q3 		$930 Buy
59
+52
+743% +$820 ﹤0.01% 1573
2023
Q2 		$136 Sell
7
-3
-30% -$58 ﹤0.01% 1869
2023
Q1 		$284 Buy
+10
New +$284 ﹤0.01% 1723